Dynavax Technologies Corp (NASDAQ:DVAX)
| 4.53 Delayed Data As of Sep 23 |  -0.39 / -7.93%Today’s Change | 1.80 Today|||52-Week Range 12.44 | -20.80% Year-to-Date |
Latest DVAX News | Press Releases
Today’s Trading
| Previous close | 4.92 |
| Today’s open | 4.95 |
| Day’s range | 4.51 - 4.98 |
| Volume | 3,684,541 |
| Average volume (3 months) | 6,975,141 |
| Market cap | $595.7M |
Data as of 3:59pm ET, 09/23/2020
Growth & Valuation
| Earnings growth (last year) | +15.07% |
| Earnings growth (this year) | +55.44% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +329.60% |
| P/E ratio | NM |
| Price/Sales | 11.70 |
| Price/Book | 55.04 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AVROAVROBIO Inc | -1.30 | -8.78% |
| SRRKScholar Rock Holding... | -0.26 | -1.44% |
| APTOAptose Biosciences I... | -0.46 | -7.36% |
| RDUSRadius Health Inc | -0.48 | -4.07% |
Data as of 4:05pm ET, 09/23/2020
Financials
| Next reporting date | November 9, 2020 |
| EPS forecast (this quarter) | -$0.20 |
| Annual revenue (last year) | $35.2M |
| Annual profit (last year) | -$152.6M |
| Net profit margin | -433.29% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Emeryville, California |
Forecasts
